Dallah’s BOD recommends the issuance of new shares to the sellers of Bagedo & Dr. Erfan Hospital Company

12/11/2014 Argaam

The BOD of Dallah Healthcare Holding Company recommended increasing the Company’s capital through issuing of 7.47 million new shares with par value of SAR 74.7 million to the sellers as part of the consideration for the acquisition of Bagedo Trading Holding Company and Mohamed Ahmed Erfan & Sons Holding Company.

 

It will represent 15.83% and 13.67% of the Company's entire issued share capital before and after the capital increase respectively, the Company said in a filing to Tadawul.

 

According to data available on “Argaam”, Dallah Healthcare signed an agreement on October 2014 to fully acquire Bagedo & Dr. Erfan General Hospital Company.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.